Northwestern Mutual Wealth Management
VTVT icon

Northwestern Mutual Wealth Management’s vTv Therapeutics VTVT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79 Buy
+2
New +$73 ﹤0.01% 4011

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northwestern Mutual Wealth Management's VTVT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 2 shares worth $79. The stake represents ﹤0.01% of the portfolio and ranks #4011 among its holdings.

35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2 shares of vTv Therapeutics worth $79 as of Q1 2026.
  • vTv Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4011 holding.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.